文献速递分子诊断临床微生物

尿液游离DNA检测结核病的研究进展与前景

Progress toward Developing Sensitive Non-Sputum-Based Tuberculosis Diagnostic Tests: the Promise of Urine Cell-Free DNA.
PubMed 文献 · J Clin Microbiol · 2021-07-19

本文评论Oreskovic等在J Clin Microbiol发表的一项优化尿液游离DNA(cfDNA)检测结核病(TB)的研究。该回顾性研究使用南非活动性肺结核患者的冻存尿样(n=73),采用序列特异性纯化联合短靶标PCR技术。总体灵敏度83.7%(95%CI:71.0-91.5),特异度100%(95%CI:86.2-100),达到WHO性能标准。

要点

  • 优化尿液cfDNA检测TB灵敏度83.7%、特异度100%,达WHO标准
  • 非HIV感染者灵敏度73.3%,涂阴TB患者灵敏度76%
  • 该技术有望成为非痰液TB诊断方法,需进一步研究验证

核心结论

  • 优化尿液cfDNA检测在早期验证中达到WHO性能标准,是非痰液TB诊断的有前景方法。

研究设计与样本

  • 回顾性临床研究,使用南非活动性肺结核患者冻存尿样(n=73),与非TB患者对比,采用序列特异性纯化联合短靶标PCR。

主要发现

  • 总体灵敏度83.7%(95%CI:71.0-91.5),特异度100%(95%CI:86.2-100)。
  • 非HIV感染者灵敏度73.3%(95%CI:48.1-89.1),涂阴TB患者灵敏度76%(95%CI:56.5-88.5)。

关键数值与推荐

  • 灵敏度83.7%(95%CI:71.0-91.5)和特异度100%(95%CI:86.2-100)满足WHO发布的性能标准。

临床怎么用

  • 该检测可作为非痰液TB诊断的潜在工具,尤其适用于难以获取痰液样本的患者。

局限性

  • 样本量较小(n=73),为回顾性研究,需进一步在前瞻性研究中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A highly accurate, non-sputum-based test for tuberculosis (TB) detection is a key priority for the field of TB diagnostics. A recent study in the Journal of Clinical Microbiology by Oreskovic and colleagues (J Clin Microbiol 59:e00074-21, 2021, https://doi.org/10.1128/JCM.00074-21) reports the performance of an optimized urine cell-free DNA (cfDNA) test using sequence-specific purification combined with short-target PCR to improve the accuracy of TB detection. Their retrospective clinical study utilized frozen urine samples (n = 73) from study participants diagnosed with active pulmonary TB in South Africa and compared results to non-TB patients in South Africa and the United States in an early-phase validation study. Overall, this cfDNA technique detected TB with a sensitivity of 83.7% (95% CI: 71.0 to 91.5) and specificity of 100% (95% CI: 86.2 to 100), which meet the World Health Organization's published performance criteria. Sensitivity was 73.3% in people without HIV (95% CI: 48.1 to 89.1) and 76% in people with smear-negative TB (95% CI: 56.5 to 88.5). In this commentary, we discuss the results of this optimized urine TB cfDNA assay within the larger context of TB diagnostics and pose additional questions for further research.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. MacLean E, Nathavitharana RR. Progress toward Developing Sensitive Non-Sputum-Based Tuberculosis Diagnostic Tests: the Promise of Urine Cell-Free DNA. J Clin Microbiol. 2021. PMID: 33980646. doi:10.1128/JCM.00706-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。